These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31549879)

  • 1. The Truth Is Unfolding About Transthyretin Cardiac Amyloidosis.
    Grodin JL; Maurer MS
    Circulation; 2019 Jul; 140(1):27-30. PubMed ID: 31549879
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac Dysautonomia and Survival in Hereditary Transthyretin Amyloidosis.
    Goldstein DS
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1442-1445. PubMed ID: 27838301
    [No Abstract]   [Full Text] [Related]  

  • 3. Transthyretin Cardiac Amyloidosis: From Rare Monogenic Disease to Common Pathway in Heart Failure?
    Culotta V; Moon JC
    Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):888-889. PubMed ID: 27514622
    [No Abstract]   [Full Text] [Related]  

  • 4. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transthyretin Amyloidosis: A "Zebra" of Many Stripes.
    Semigran MJ
    J Am Coll Cardiol; 2016 Jul; 68(2):173-5. PubMed ID: 27386770
    [No Abstract]   [Full Text] [Related]  

  • 7. Early identification of transthyretin-related hereditary cardiac amyloidosis.
    Arbustini E; Merlini G
    JACC Cardiovasc Imaging; 2014 May; 7(5):511-4. PubMed ID: 24831211
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding Changes in Functional Capacity After TTR Stabilization in Patients With Transthyretin Cardiac Amyloidosis.
    Cuddy SAM
    Circ Heart Fail; 2022 Jul; 15(7):e009387. PubMed ID: 35766044
    [No Abstract]   [Full Text] [Related]  

  • 9. Recognizing Transthyretin Cardiac Amyloidosis in Patients With Aortic Stenosis: Impact on Prognosis.
    Sperry BW; Jones BM; Vranian MN; Hanna M; Jaber WA
    JACC Cardiovasc Imaging; 2016 Jul; 9(7):904-906. PubMed ID: 27085437
    [No Abstract]   [Full Text] [Related]  

  • 10. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac transthyretin/leukocyte chemotactic factor (LECT) 2 double amyloidosis in a patient suffering from heart failure.
    Greulich S; Mahrholdt H; Casadonte R; Steinmüller-Magin L; Latus J; Blessing F; Kriegsmann J; Bekeredjian R; Gawaz M; Klingel K
    Clin Res Cardiol; 2023 Mar; 112(3):444-449. PubMed ID: 35925392
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene Silencing Therapy in Hereditary (Variant) Transthyretin Cardiac Amyloidosis: A Puzzling Case of Decreasing Pyrophosphate Uptake on Scintigraphy.
    Smiley DA; Einstein AJ; Mintz A; Shetty M; Chan N; Helmke ST; Bhatia K; Goldner K; Brannagan TH; Santana DD; Maurer MS
    Circ Cardiovasc Imaging; 2023 Aug; 16(8):e015243. PubMed ID: 37334703
    [No Abstract]   [Full Text] [Related]  

  • 13. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation.
    Tini G; Vianello PF; Gemelli C; Grandis M; Canepa M
    J Cardiovasc Transl Res; 2019 Dec; 12(6):514-516. PubMed ID: 30604309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transthyretin Cardiac Amyloidosis in Black Americans.
    Shah KB; Mankad AK; Castano A; Akinboboye OO; Duncan PB; Fergus IV; Maurer MS
    Circ Heart Fail; 2016 Jun; 9(6):e002558. PubMed ID: 27188913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition and Implications of Undiagnosed Cardiac Amyloid Patients in HFpEF Trials.
    Cheng RK; Maurer MS
    JACC Heart Fail; 2021 Nov; 9(11):803-806. PubMed ID: 34509407
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transthyretin-related hereditary amyloidosis].
    Vionnet J; Pascual M; Kuntzer T; Yerly P; Moradpour D
    Rev Med Suisse; 2016 Aug; 12(528):1434-1440. PubMed ID: 28675284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis.
    Schmidt M; Wiese S; Adak V; Engler J; Agarwal S; Fritz G; Westermark P; Zacharias M; Fändrich M
    Nat Commun; 2019 Nov; 10(1):5008. PubMed ID: 31676763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.
    Watanabe T; Obayashi K; Misumi Y; Tasaki M; Shinriki S; Ando T; Akagami T; Ueda M; Yamashita T; Hirotani S; Ando Y
    Amyloid; 2017 Mar; 24(sup1):119. PubMed ID: 28434332
    [No Abstract]   [Full Text] [Related]  

  • 19. Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis.
    Steinebrei M; Gottwald J; Baur J; Röcken C; Hegenbart U; Schönland S; Schmidt M
    Nat Commun; 2022 Oct; 13(1):6398. PubMed ID: 36302762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
    Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
    Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.